Vincent Medical Holdings Limited

HKEX:1612.HK

0.395 (HKD) • At close September 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 380.706356.738361.235348.511280.731407.016370.704653.037502.346255.676246.524260.942227.088240.901205.401229.406237.941224.54223.629112.04297.24497.24497.24497.24481.12381.12381.12381.123
Cost of Revenue 261.525235.177242.409219.945243.944273.603245.013384.104277.042177.367162.826178.124154.298161.473134.526161.563160.022152.557155.81177.09268.47868.47868.47868.47859.07359.07359.07359.073
Gross Profit 119.181121.561118.826128.56636.787133.413125.691268.933225.30478.30983.69882.81872.7979.42870.87567.84377.91971.98367.81834.9528.76628.76628.76628.76622.0522.0522.0522.05
Gross Profit Ratio 0.3130.3410.3290.3690.1310.3280.3390.4120.4490.3060.340.3170.3210.330.3450.2960.3270.3210.3030.3120.2960.2960.2960.2960.2720.2720.2720.272
Reseach & Development Expenses 14.94217.91618.14720.14416.53818.84320.40220.82315.75418.04611.69616.3549.74610.9558.1925.7473.843.9043.281000000000
General & Administrative Expenses 047.44551.62351.2950.38845.72542.01447.90157.79553.89447.94247.24141.81738.69345.9236.76533.34728.57624.61914.45712.14912.14912.14912.14910.74310.74310.74310.743
Selling & Marketing Expenses 020.14718.78117.00814.96519.00918.6732.52422.20316.50215.61715.20912.49915.937.1378.4187.0676.6547.7413.5993.6973.6973.6973.6972.872.872.872.87
SG&A 73.6767.87971.20468.29865.35368.02160.68480.36380.14250.65551.8962.52254.31654.62353.05745.18340.41435.2332.3618.05615.84615.84615.84615.84613.61313.61313.61313.613
Other Expenses 000-2.5240-11.69700000000000-1.188-0.123-0.123-0.441-0.441-0.441-0.441-0.379-0.379-0.379-0.379
Operating Expenses 88.61285.79589.35190.96681.89198.56181.086101.18695.89668.70163.58661.80555.04477.39853.05943.15154.63339.82730.92817.93415.40515.40515.40515.40513.23413.23413.23413.234
Operating Income 30.56935.76629.47537.6-45.10434.85244.605167.747129.4089.60820.11227.75119.36724.95118.11424.49840.41736.95135.7513.91911.8411.8411.8411.847.997.997.997.99
Operating Income Ratio 0.080.10.0820.108-0.1610.0860.120.2570.2580.0380.0820.1060.0850.1040.0880.1070.170.1650.160.1240.1220.1220.1220.1220.0980.0980.0980.098
Total Other Income Expenses Net 3.454-4.0242.881-8.1781.83-10.5653.167-8.9510.633-8.896-0.076-7.022-1.965-23.072-0.3760.108-17.327-4.691.1613.3751.6491.6491.6491.6490.8790.8790.8790.879
Income Before Tax 34.02331.74232.35629.422-43.27424.28747.772158.796130.0410.71220.03620.72917.4021.87917.73824.60623.0932.26136.91117.29313.4913.4913.4913.498.8698.8698.8698.869
Income Before Tax Ratio 0.0890.0890.090.084-0.1540.060.1290.2430.2590.0030.0810.0790.0770.0080.0860.1070.0970.1440.1650.1540.1390.1390.1390.1390.1090.1090.1090.109
Income Tax Expense 0.2993.4325.2752.2160.6580.5015.60917.13619.5132.0433.3940.2394.1673.6084.5554.8315.78310.6458.161-0.6212.8912.8912.8912.8912.1162.1162.1162.116
Net Income 33.28830.67526.626.965-44.36318.83641.859125.02391.842-2.14213.66718.03812.9050.7912.36517.10412.13836.13522.01817.91410.59910.59910.59910.5996.7536.7536.7536.753
Net Income Ratio 0.0870.0860.0740.077-0.1580.0460.1130.1910.183-0.0080.0550.0690.0570.0030.060.0750.0510.1610.0980.160.1090.1090.1090.1090.0830.0830.0830.083
EPS 0.0520.0480.0410.041-0.0680.0290.0640.190.14-0.0030.0210.0280.020.0010.0190.0270.0250.0890.0540.0280.0220.0220.0220.0220.0140.0140.0140.014
EPS Diluted 0.0520.0480.0410.041-0.0680.0290.0630.190.14-0.0030.0210.0280.020.0010.0190.0270.0250.0890.0540.0280.0220.0220.0220.0220.0140.0140.0140.014
EBITDA 48.65754.57249.32157.492-24.04454.42665.094187.386146.78524.51133.76234.34627.46931.47424.23430.8246.71143.18842.82517.24714.93314.93314.93314.93310.69610.69610.69610.696
EBITDA Ratio 0.1280.1530.1370.165-0.0860.1340.1760.2870.2920.0960.1370.1320.1210.1310.1180.1340.1960.1920.1920.1540.1540.1540.1540.1540.1320.1320.1320.132